Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Novo Nordisk,Liraglutide,Diabetes - type 2,Liraglutide (Victoza),Recommended for decline,Community and Hospital,Alimentary Tract and Metabolism
